Reports for SANDOZ SITAGLIPTIN-METFORMIN
Brand name
SANDOZ SITAGLIPTIN-METFORMIN
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02503956 |
Ingredients
METFORMIN HYDROCHLORIDE SITAGLIPTIN |
Ingredient Strength
500 MG 50 MG |
ATC Code
A10BD |
ATC Descriptor
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| SANDOZ SITAGLIPTIN-METFORMIN | 500FCT | Resolved | 2023-05-25 | 2023-07-11 | 193057 |
| SANDOZ SITAGLIPTIN-METFORMIN | 60FCT | Resolved | 2023-08-29 | 2023-09-26 | 203193 |
| SANDOZ SITAGLIPTIN-METFORMIN | 500FCT | Resolved | 2023-10-02 | 2023-10-11 | 205811 |
| SANDOZ SITAGLIPTIN-METFORMIN | 60FCT | Resolved | 2023-12-19 | 2024-01-24 | 213821 |
| SANDOZ SITAGLIPTIN-METFORMIN | 60FCT BO | Resolved | 2024-02-26 | 2024-03-06 | 220558 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0